Celldex Therapeutics Company Profile (NASDAQ:CLDX)

About Celldex Therapeutics

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (rindopepimut and CDX-110) is a therapeutic vaccine in clinical studies for the treatment of glioblastoma patients that express a specific cancer marker known as type III epidermal growth factor receptor mutation (EGFRvIII). Its Glembatumumab vedotin (CDX-011) is a targeted antibody-drug conjugate for the treatment of metastatic melanoma. Its Varlilumab (CDX-1127) is an immune modulating antibody that is designed to enhance a patient's immune response against their cancer. Its earlier stage drug candidates in clinical development include CDX-1401, which is a targeted immunotherapeutic aimed at antigen presenting cells (APC) for cancer indications and CDX-301, which is an immune cell mobilizing agent and dendritic cell growth factor.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: CLDX
• CUSIP: 15117B10

Key Metrics:

• Previous Close: $3.80
• 50 Day Moving Average: $3.77
• 200 Day Moving Average: $4.13
• 52-Week Range: $2.96 - $18.62
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -3.34
• P/E Growth: 0.00
• Market Cap: $406.20M
• Outstanding Shares: 100,545,000
• Beta: 3.26

Profitability:

• Net Margins: -2,383.60%
• Return on Equity: -47.59%
• Return on Assets: -41.57%

Debt:

• Current Ratio: 11.44%
• Quick Ratio: 11.44%

Additional Links:

• Visit Celldex Therapeutics' Official Website
• View CLDX on Google Finance
• View CLDX on Yahoo Finance
• View CLDX's Company Profile on Reuters
• Search for Celldex Therapeutics Inc. on Google

Companies Related to Celldex Therapeutics:

• Orthofix International NV (NASDAQ:OFIX)
• Global Blood Therapeutics (NASDAQ:GBT)
• ANI Pharmaceuticals (NASDAQ:ANIP)
• Cardiovascular Systems (NASDAQ:CSII)
• U.S. Physical Therapy (NYSE:USPH)
• Wave Life Sciences Pte. (NASDAQ:WVE)
• Tobira Therapeutics (NASDAQ:TBRA)
• Ziopharm Oncology (NASDAQ:ZIOP)
• NovoCure (NASDAQ:NVCR)
• K2M Group Holdings (NASDAQ:KTWO)

Earnings

Earnings History for Celldex Therapeutics (NASDAQ:CLDX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/3/2016
8/8/2016	Q2	($0.34)	($0.32)	$0.96 million	$1.39 million	View	Listen
5/5/2016	Q1 16	($0.35)	($0.35)	$1.06 million	$1.30 million	View	N/A
2/25/2016	Q415	($0.35)	($0.33)	$0.80 million	$1.80 million	View	Listen
11/5/2015	Q3	($0.35)	($0.32)			View	N/A
8/10/2015	Q215	($0.34)	($0.33)		$2.20 million	View	Listen
4/29/2015	Q115	($0.36)	($0.33)	$0.52 million	$0.49 million	View	N/A
2/24/2015	Q314	($0.35)	($0.36)	$0.49 million	$1.50 million	View	N/A
11/5/2014	Q3	($0.31)	($0.31)	$0.43 million	$1.10 million	View	N/A
8/6/2014	Q214	($0.32)	($0.32)	$0.38 million	$0.60 million	View	N/A
5/1/2014		($0.25)	($0.33)	$0.34 million	$0.40 million	View	N/A
3/3/2014	Q413	($0.28)	($0.27)	$0.27 million	$0.62 million	View	N/A
11/5/2013	Q313	($0.24)	($0.29)	$0.09 million	$1.00 million	View	N/A
8/6/2013	Q2 2013	($0.22)	($0.24)	$1.57 million	$0.97 million	View	N/A
5/2/2013	Q1 2013	($0.22)	($0.23)	$2.65 million	$2.41 million	View	N/A
3/7/2013	Q4 2012	($0.25)	($0.27)	$2.45 million	$3.65 million	View	N/A
11/1/2012	Q312	($0.24)	($0.25)	$2.07 million	$3.11 million	View	N/A
8/10/2012		($0.25)	($0.23)			View	N/A
5/3/2012		($0.25)	($0.27)			View	N/A
3/7/2012		($0.26)	($0.29)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Celldex Therapeutics (NASDAQ:CLDX)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	6	($0.39)	($0.34)	($0.36)
Q2 2016	7	($0.39)	($0.29)	($0.34)
Q3 2016	6	($0.38)	($0.27)	($0.32)
Q4 2016	7	($0.39)	($0.20)	($0.32)
Q1 2017	1	($0.34)	($0.34)	($0.34)
Q3 2017	1	($0.24)	($0.24)	($0.24)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Celldex Therapeutics (NASDAQ:CLDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Celldex Therapeutics (NASDAQ:CLDX)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/2/2016	Tibor Keler	VP	Buy	3,000	$3.32	$9,960.00
11/23/2015	Avery W. Catlin	CFO	Sell	25,000	$18.00	$450,000.00
8/25/2015	Larry Ellberger	Director	Buy	5,000	$14.00	$70,000.00
8/20/2015	Larry Ellberger	Director	Buy	5,000	$15.00	$75,000.00
8/18/2015	Larry Ellberger	Director	Buy	5,000	$15.95	$79,750.00
8/13/2015	Anthony S Marucci	CEO	Buy	5,800	$16.81	$97,498.00
8/13/2015	Larry Ellberger	Director	Buy	5,000	$16.59	$82,950.00
6/15/2015	Avery W Catlin	CFO	Sell	25,000	$24.59	$614,750.00
12/6/2013	Avery Catlin	CFO	Sell	183,333	$24.50	$4,491,658.50
12/6/2013	Larry Ellberger	Director	Sell	17,728	$24.50	$434,336.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Celldex Therapeutics (NASDAQ:CLDX)

Date	Headline
	ETF’s with exposure to Celldex Therapeutics, Inc. : September 30, 2016 (NASDAQ:CLDX) www.capitalcube.com - September 30 at 4:40 PM
	Active biotech company shares in the news: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Celgene Corporation ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 30 at 9:17 AM
	Biotech Stocks Worth Chasing: MannKind Corp. (MNKD), Celldex Therapeutics, Inc. (CLDX) - The Independent Republic (NASDAQ:CLDX) theindependentrepublic.com - September 30 at 9:17 AM
	Celldex Therapeutics, Inc. – Value Analysis (NASDAQ:CLDX) : September 29, 2016 (NASDAQ:CLDX) www.capitalcube.com - September 29 at 4:08 PM
	Stock Buzz- Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Hot Stocks Point (NASDAQ:CLDX) www.hotstockspoint.com - September 28 at 4:08 PM
	Hot Biotech Stocks Recap: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Amgen Inc. (NASDAQ:AMGN) - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 28 at 4:08 PM
	Celldex Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CLDX-US : September 28, 2016 (NASDAQ:CLDX) www.capitalcube.com - September 28 at 9:06 AM
	Why Celldex Therapeutics, Inc. Ran Higher Today (NASDAQ:CLDX) www.fool.com - September 27 at 4:27 PM
	HC Stocks in Focus! Celldex Therapeutics, Inc. (CLDX), Northwest Biotherapeutics, Inc (NASDAQ:NWBO) - share market updates (press release) (NASDAQ:CLDX) sharemarketupdates.com - September 26 at 4:29 PM
	Today's Chart On Watch: Celldex Therapeutics, Inc. Can't Be More Risky. The Stock Formed a Multiple Bottom Chart ... - Chester News (NASDAQ:CLDX) www.chesterindependent.com - September 26 at 4:29 PM
	Celldex Therapeutics : to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable (NASDAQ:CLDX) www.4-traders.com - September 24 at 8:29 AM
	Active Biotech Stock News: Amicus Therapeutics, Inc. (FOLD ... - The Independent Republic (NASDAQ:CLDX) theindependentrepublic.com - September 23 at 3:39 PM
	Celldex Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable (NASDAQ:CLDX) www.publicnow.com - September 23 at 3:39 PM
	Eye-Catching Stock: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Clean Energy Fuels Corp. (NASDAQ:CLNE) - Newburgh Press (NASDAQ:CLDX) newburghpress.com - September 22 at 9:53 AM
	2 Biotech Stocks News And Price Trends: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Navidea Biopharmaceuticals ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 21 at 4:53 PM
	Long Term Growth review of Celldex Therapeutics (CLDX) - Newburgh Press (NASDAQ:CLDX) newburghpress.com - September 21 at 8:17 AM
	Celldex Therapeutics Remains a Guessing Game - Investopedia (NASDAQ:CLDX) www.investopedia.com - September 21 at 8:17 AM
	Analysts Valuations For Two Stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), ZIOPHARM Oncology Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 21 at 8:17 AM
	Celldex Therapeutics Remains a Guessing Game (NASDAQ:CLDX) www.investopedia.com - September 21 at 8:17 AM
	News review of 2 biotech stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Intrexon Corporation (NYSE:XON) - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 20 at 10:03 AM
	HC Stocks Vigilant! Catalent Inc (CTLT), Celldex Therapeutics, Inc. (NASDAQ:CLDX) - share market updates (press release) (NASDAQ:CLDX) sharemarketupdates.com - September 19 at 8:58 AM
	Active biotech company shares in the news: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Inovio Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 16 at 4:09 PM
	Celldex Therapeutics, Inc. (NASDAQ:CLDX) Insider Trading Report - Newburg Press (NASDAQ:CLDX) newburghpress.com - September 16 at 4:09 PM
	Analysts Valuations For Two Stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Dunkin Brands Group Inc (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 16 at 4:09 PM
	Active biotech company shares in the news: Celldex Therapeutics ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 15 at 4:36 PM
	Is A Celldex Therapeutics, Inc. (NASDAQ:CLDX) Short Squeeze On ... - Street Register (NASDAQ:CLDX) streetregister.com - September 15 at 4:36 PM
	Is A Celldex Therapeutics, Inc. (NASDAQ:CLDX) Short Squeeze On The Cards? (NASDAQ:CLDX) streetregister.com - September 15 at 10:52 AM
	ACADIA Pharmaceuticals : Biotech Stocks on Investors' Radar -- Eleven Biotherapeutics, CytRx, Celldex Therapeutics, and ACADIA Pharma (NASDAQ:CLDX) www.4-traders.com - September 14 at 4:19 PM
	Key FDA Decisions and Trial Results Coming in the Next 2 Months (NASDAQ:CLDX) 247wallst.com - September 14 at 8:30 AM
	Why Celldex Therapeutics, Inc. Stock Sank 28.1% in August -- The ... - Motley Fool (NASDAQ:CLDX) www.fool.com - September 13 at 9:04 AM
	ETF’s with exposure to Celldex Therapeutics, Inc. : September 12, 2016 (NASDAQ:CLDX) www.capitalcube.com - September 12 at 4:05 PM
	Why Celldex Therapeutics, Inc. Stock Sank 28.1% in August (NASDAQ:CLDX) www.fool.com - September 12 at 8:13 AM
	News review of 2 biotech stocks: Celldex Therapeutics, Inc. (NASDAQ:CLDX), BioMarin Pharmaceutical Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 10 at 8:54 AM
	Celldex Therapeutics, Inc.'s (CLDX) (NASDAQ:CLDX) 10thousandcouples.com - September 9 at 9:03 AM
	Biotechnology Stocks under Discussion: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Celldex Therapeutics ... - Post Registrar (NASDAQ:CLDX) postregistrar.com - September 8 at 5:25 AM
	Analysts Valuations For Two Stocks: Celldex Therapeutics (NASDAQ:CLDX), 3D Systems (NYSE:DDD) - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 7 at 8:21 AM
	Trading the Biotech News: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Juno Therapeutics Inc. (NASDAQ:JUNO) - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - September 3 at 3:59 PM
	Intraday Active Biotech Stocks News: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Celldex Therapeutics, Inc ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - August 29 at 3:38 PM
	Analyst Outlook on Price Target: Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Post Registrar (NASDAQ:CLDX) postregistrar.com - August 29 at 3:38 PM
	ETF’s with exposure to Celldex Therapeutics, Inc. : August 29, 2016 (NASDAQ:CLDX) www.capitalcube.com - August 29 at 3:38 PM
	3 Reasons Celldex Therapeutics, Inc. Stock Could Fall (NASDAQ:CLDX) www.fool.com - August 27 at 8:58 AM
	Analysts Valuations For Two Stocks: JetBlue Airways (NASDAQ:JBLU), Celldex Therapeutics (NASDAQ:CLDX) - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - August 23 at 8:27 AM
	Watch List: Abbott Laboratories (NYSE:ABT), Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Post Registrar (NASDAQ:CLDX) postregistrar.com - August 22 at 4:21 PM
	ETF’s with exposure to Celldex Therapeutics, Inc. : August 18, 2016 (NASDAQ:CLDX) www.capitalcube.com - August 18 at 9:32 PM
	Biotech news that matter for investors: Celldex Therapeutics (NASDAQ:CLDX), TetraLogic Pharmaceuticals (NASDAQ ... - The Voice Registrar (NASDAQ:CLDX) voiceregistrar.com - August 17 at 10:59 AM
	Biotech Industry on the Upswing after Rocky Start to 2016 (NASDAQ:CLDX) news.investornetwork.com - August 17 at 10:59 AM
	Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:CLDX) www.capitalcube.com - August 16 at 4:19 PM
	CELLDEX THERAPEUTICS, INC. Financials (NASDAQ:CLDX) finance.yahoo.com - August 16 at 4:19 PM
	How Risky Is Celldex Therapeutics, Inc.? (NASDAQ:CLDX) www.fool.com - August 12 at 2:18 PM
	Company Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Names Elizabeth Crowley as Chief Product ... - Smarter Analyst (NASDAQ:CLDX) www.smarteranalyst.com - August 12 at 11:48 AM

Social

Celldex Therapeutics (NASDAQ:CLDX) Chart for Saturday, October, 1, 2016